Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa

被引：9

作者：

Mosam, A ^{[1
]}

Cassol, E

Page, T

Bodasing, U

Cassol, S

Dawood, H

Friedland, GH

Scadden, DT

Aboobaker, J

Jordaan, JP

Lalloo, UG

Esterhuizen, TM

Coovadia, HM

机构：

[1] Africa Ctr Hlth & Populat Studies, Dept Dermatol, Durban, South Africa

[2] Africa Ctr Hlth & Populat Studies, Dept Mol Virol & Bioinformat, Durban, South Africa

[3] Yale Univ, Sch Med, Ctr HIV AIDS Networking, New Haven, CT USA

[4] Yale Univ, Sch Med, Dept Infect Dis, New Haven, CT USA

[5] Yale Univ, Sch Med, AIDS Programme, New Haven, CT USA

[6] Harvard Univ, Sch Med, MGH Canc Ctr, Dept Haematol Malignancies, Cambridge, MA 02138 USA

[7] Univ KwaZulu, Nelson R Mandela Sch Med, Fac Hlth Sci, Dept Radiotherapy & Oncol, Natal, South Africa

[8] Univ KwaZulu, Nelson R Mandela Sch Med, Fac Hlth Sci, Med Bioeth Unit, Natal, South Africa

[9] Univ KwaZulu, Nelson R Mandela Sch Med, Fac Hlth Sci, Victor Diatz Chair HIV AIDS Res, Natal, South Africa

来源：

AIDS | 2005年 / 19卷 / 04期

关键词：

D O I：

10.1097/01.aids.0000161775.36652.85

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Generic antiretroviral drugs are pivotal in the implementation of WHO's '3 by 5' programme. However, clinical experience with generics in sub-Saharan Africa is insufficiently documented. We report on 50 patients with HIV-associated Kaposi's sarcoma treated with generic fixed-dose highly active antiretroviral therapy. At 52 weeks, 74% achieved an undetectable viral load of < 50 copies/ml, 86% achieved < 400 copies/ml, and a 3.1 log(10) decline from baseline. Side-effects were minimal. The outcomes support the use of generic antiretroviral therapy.

引用

页码：441 / 443

页数：3

共 50 条

[21] Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities
Krown, Susan E.
CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) : 463 - 468
[22] The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa
Byakwaga, Helen
Hunt, Peter W.
Laker-Oketta, Miriam
Glidden, David V.
Huang, Yong
Bwana, Bosco M.
Mocello, A. Rain
Bennett, John
Walusansa, Victoria
Dollard, Sheila C.
Bangsberg, David R.
Mbidde, Edward K.
Martin, Jeffrey N.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (03) : 296 - 303
[23] Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone
Paparizos, VA
Kyriakis, KP
Papastamopoulos, V
Hadjivassiliou, M
Stavrianeas, NG
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (02) : 257 - 258
[24] MAPPING THE INCIDENCE OF KAPOSI SARCOMA AMONG CHILDREN IN SUB-SAHARAN AFRICA
Rees, C. A.
Slone, J. S.
Lukolyo, H.
Keating, E. M.
Mehta, P. S.
Scheurer, M. E.
Lubega, J.
PEDIATRIC BLOOD & CANCER, 2015, 62 : S371 - S372
[25] Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma
Engels, EA
Biggar, RJ
Marshall, VA
Walters, MAKL
Gamache, CJ
Whitby, D
Goedert, JJ
AIDS, 2003, 17 (12) : 1847 - 1851
[26] AIDS IN SUB-SAHARAN AFRICA
不详
LANCET, 1988, 1 (8597) : 1260 - 1261
[27] A case of AIDS-associated oral Kaposi's sarcoma of the tongue
Yoshida, Ryoji
Nakayamaa, Hideki
Takahashi, Nozomu
Nagata, Masashi
Tanaka, Takuya
Nakamoto, Masafumi
Sato, Hideto
Miyakawa, Toshikazu
Mitsuya, Hiroaki
Shinohara, Masanori
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2014, 26 (02) : 170 - 174
[28] AIDS IN SUB-SAHARAN AFRICA
KONOTEYAHULU, FID
LANCET, 1988, 2 (8603) : 163 - 164
[29] Non cutaneous AIDS-associated Kaposi's sarcoma.
Stebbing, J.
Mazhar, D.
Palmieri, C.
Thirlwell, C.
Powles, T.
Nelson, M.
Gazzard, B.
Bower, M.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 533S - 533S
[30] LYMPHANGIOSCINTIGRAPHY IN AIDS-ASSOCIATED KAPOSI-SARCOMA
WITTE, MH
FIALA, M
MCNEILL, GC
WITTE, CL
WILLIAMS, WH
SZABO, J
AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 155 (02) : 311 - 315

← 1 2 3 4 5 →